Cancer Cachexia

Overview of cancer cachexia.- Pathophysiology.- Impact of cancer cachexia.- Patient assessment.- Managing cancer cachexia.- Emerging treatments, current challenges, and future directions.

David Blum MD obtained his medical degree from the University of Zürich in 2002 and received the Swiss board certification of Internal Medicine in 2009 and Medical Oncology in 2011. He was a resident doctor and research fellow (EPCRC) at Oncology DIM Kantonsspital St. Gallen in Switzerland and is currently undergoing EURO IMPACT - Marie Curie PhD training fellow at European Palliative Research Center NTNU in Trondheim, Norway. His main research interests include symptom assessment and the role of computer assistance, cancer cachexia, physical activity, end of life care, and integration of oncology and palliative care. Dr. Egidio Del Fabbro (MD) obtained his medical degree from the University of the Witwatersrand in South Africa. He completed his residency in Internal Medicine at Barnes-Jewish Hospital, Washington University. He was co-founder of the Cachexia Clinic at MD Anderson Cancer Center and is currently Director of the Palliative Care Program at Virginia Commonwealth University. Dr. Del Fabbro's research interest lies in developing clinical trials for cancer-related cachexia and fatigue. He is the senior editor for the textbook, Nutrition and the Cancer Patient. Professor Akio Inui (MD, PhD) is the Chairman of the department of Psychosomatic Internal Medicine of Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. Professor Inui completed his MD and PhD degrees at Kobe University, Japan. Professor Inui is recognized for his studies in elucidating the role of gut-brain peptides in the regulation of gastrointestinal motility, feeding, and body weight, and the identification of the ghrelin-neuropeptide Y pathway from stomach to brain in the pathogenesis of obesity and cachexia. Professor Inui has authored more than 250 peer-reviewed publications. His efforts are now focused on translational research on peptides that bridges the gap between basic and clinical disciplines for better understanding and management of human behavioral